Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.45 EUR
−28.89 M EUR
28.57 M EUR
43.86 M
About GENFIT
Sector
CEO
Pascal Prigent
Headquarters
Loos
Website
Founded
1999
ISIN
FR0004163111
FIGI
BBG000QL06N5
Genfit SA is a biopharmaceutical company involved in drug discovery and development for the early diagnosis, prevention and treatment of cardiometabolic diseases. The company focuses on the discovery and development of drug candidates in areas of high unmet medical needs corresponding to a lack of suitable treatments. It focuses on medicines to market for patients with metabolic, inflammatory, autoimmune and fibrotic diseases that affect the liver. The company was founded by Jean-François Mouney, Florence Séjourné, and Bart Staels in September 1999 and is headquartered in Loos, France.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of XUP is 3.60 EUR — it has decreased by −2.44% in the past 24 hours. Watch GENFIT SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange GENFIT SA stocks are traded under the ticker XUP.
XUP stock has fallen by −1.23% compared to the previous week, the month change is a 5.42% rise, over the last year GENFIT SA has showed a 7.63% increase.
We've gathered analysts' opinions on GENFIT SA future price: according to them, XUP price has a max estimate of 12.54 EUR and a min estimate of 7.00 EUR. Watch XUP chart and read a more detailed GENFIT SA stock forecast: see what analysts think of GENFIT SA and suggest that you do with its stocks.
XUP stock is 3.94% volatile and has beta coefficient of 1.59. Track GENFIT SA stock price on the chart and check out the list of the most volatile stocks — is GENFIT SA there?
Today GENFIT SA has the market capitalization of 183.25 M, it has decreased by −0.40% over the last week.
Yes, you can track GENFIT SA financials in yearly and quarterly reports right on TradingView.
GENFIT SA is going to release the next earnings report on Apr 10, 2025. Keep track of upcoming events with our Earnings Calendar.
XUP earnings for the last half-year are 0.53 EUR per share, whereas the estimation was 0.31 EUR, resulting in a 70.97% surprise. The estimated earnings for the next half-year are 0.14 EUR per share. See more details about GENFIT SA earnings.
GENFIT SA revenue for the last half-year amounts to 61.20 M EUR, despite the estimated figure of 47.50 M EUR. In the next half-year revenue is expected to reach 37.55 M EUR.
XUP net income for the last half-year is 30.31 M EUR, while the previous report showed −8.04 M EUR of net income which accounts for 477.00% change. Track more GENFIT SA financial stats to get the full picture.
No, XUP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 25, 2025, the company has 159.00 employees. See our rating of the largest employees — is GENFIT SA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENFIT SA EBITDA is 17.71 M EUR, and current EBITDA margin is −122.29%. See more stats in GENFIT SA financial statements.
Like other stocks, XUP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENFIT SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENFIT SA technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENFIT SA stock shows the sell signal. See more of GENFIT SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.